Ptc Therapeutics (PTCT) EPS (Diluted) (QoQ) (2012 - 2026)
Ptc Therapeutics (PTCT) EPS (Diluted) (QoQ) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Ptc Therapeutics | 6.34 Bn | 4.45 Bn | 244.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 97.60% |
| Dec 31, 2025 | -878.11% |
| Sep 30, 2025 | 121.99% |
| Jun 30, 2025 | -108.27% |
| Mar 31, 2025 | 1,269.98% |
| Dec 31, 2024 | 38.16% |
| Sep 30, 2024 | -7.26% |
| Jun 30, 2024 | -7.98% |
| Mar 31, 2024 | 42.49% |
| Dec 31, 2023 | -18.01% |
| Sep 30, 2023 | 33.72% |
| Jun 30, 2023 | -41.21% |
| Mar 31, 2023 | 20.89% |
| Dec 31, 2022 | -56.17% |
| Sep 30, 2022 | 28.41% |
| Jun 30, 2022 | -19.75% |
| Mar 31, 2022 | 12.47% |
| Dec 31, 2021 | -7.40% |
| Sep 30, 2021 | -12.61% |
| Jun 30, 2021 | 8.28% |